1-68482103-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001114120.3(DEPDC1):āc.1705A>Gā(p.Ile569Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,608,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001114120.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEPDC1 | NM_001114120.3 | c.1705A>G | p.Ile569Val | missense_variant | 8/12 | ENST00000456315.7 | NP_001107592.1 | |
DEPDC1 | NM_017779.6 | c.911-491A>G | intron_variant | NP_060249.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEPDC1 | ENST00000456315.7 | c.1705A>G | p.Ile569Val | missense_variant | 8/12 | 1 | NM_001114120.3 | ENSP00000412292.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152064Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000287 AC: 7AN: 243528Hom.: 0 AF XY: 0.0000227 AC XY: 3AN XY: 132266
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1456142Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 724210
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152064Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74274
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.1705A>G (p.I569V) alteration is located in exon 8 (coding exon 8) of the DEPDC1 gene. This alteration results from a A to G substitution at nucleotide position 1705, causing the isoleucine (I) at amino acid position 569 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at